+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alcaftadine"

Eye Allergy Therapeutics Market Report 2025 - Product Thumbnail Image

Eye Allergy Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Eye Allergy Treatment Market - Product Thumbnail Image

Eye Allergy Treatment Market

  • Report
  • September 2025
  • 150 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Alcaftadine is a type of antihistamine used to treat allergies. It is a selective H1-receptor antagonist, meaning it blocks the action of histamine, a chemical released by the body during an allergic reaction. Alcaftadine is available in both over-the-counter and prescription forms, and is used to treat a variety of allergic conditions, including hay fever, hives, and itching. It is also used to treat eye allergies, such as conjunctivitis. Alcaftadine is generally well-tolerated, with few side effects. The Alcaftadine market is a subset of the larger allergy drug market. It is a competitive market, with a variety of manufacturers offering different formulations of the drug. Alcaftadine is available in both generic and brand-name forms, and is widely available in pharmacies and online. Some companies in the Alcaftadine market include Mylan, Sandoz, Teva Pharmaceuticals, and Perrigo. Show Less Read more